Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

TNFR:Fc evaluated clinically for congestive heart failure

April 9, 1998

Leukocyte activation inhibitor active in animal models of myocardial infarction

April 6, 1998

Green Cross reveals potent, selective angiotensin II antagonists

April 6, 1998

Positive results obtained with apoptosis suppressant in heart attack

April 3, 1998

Immunomedics discovers immunoangioplasty technology, seeks corporate partners

April 3, 1998

FR-146801 inhibits intimal thickening in a rat balloon injury model

April 2, 1998

GH secretagogue shows beneficial cardiovascular activity in rats

April 2, 1998

Cardioprotective effects of new Lederle compound assessed

April 2, 1998

Results from experimental studies suggest potential of MCC-135 in AMI, heart failure

April 1, 1998

Ajinomoto presents pharmacological results with novel antiarrhythmic agent

April 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.